A person's 'bioenergetic age' -- or how youthfully their cells generate energy -- might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research shows. The study ...
Alzheimer's disease has a long preclinical phase in which neuropathological changes, such as amyloid β (Aβ) and tau pathology, accumulate over many years.1 This preclinical phase provides an ...
A new study published by the Alzheimer's Association links biological age measured through blood metabolites to increased all ...
A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease ...
Research shows that blood metabolite profiles can indicate dementia risk, offering a potential tool for early detection and prevention of cognitive decline.
A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age. In the future, blood-based biomarkers associated with Alzheimer's disease ...
New bio-marker blood tests for Alzheimer's disease should be viewed cautiously when it comes to participants, according to Dr ...
Clues to a degenerative disease could be showing up sooner than we realize. Alzheimer’s disease primarily affects people over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results